CASI - CASI Pharmaceuticals Inc
Previous close
6.54
0 0%
Share volume: 3,853
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$6.54
0.00
0.00%
Summary score
9%
Profitability
0%
Dept financing
11%
Liquidity
60%
Performance
5%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 31-Dec-2018 - 31-Dec-2022
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-14.45%
Return on assets
-7.01%
Return on sales
-204.97%
Return on invested capital
-45.85%
Total debt ratio
35.07%
Debt ratio change over timeo
-2.73%
Current Ratio
8.8%
Quick Ratio
8.55%
Cash Position Ratio
7.42%
Short-term ratios 31-Dec-2021 - 31-Dec-2022
The data are presented for the financials results of the quarters of the last year.
Return on equity
-18.8%
Return on assets
-5.48%
Return on sales
-61.7%
Return on invested capital
-93.62%
Total debt ratio
47.81%
Debt ratio change over timeo
-3.81%
Current Ratio
3.3%
Quick Ratio
2.98%
Cash Position Ratio
1.97%
Last quarter ratios 31-Dec-2022
The data are presented for the financials results of the last quarter.
Return on equity
-43.83%
Return on assets
-6.18%
Return on sales
-33.43%
Return on invested capital
-336.5%
Total debt ratio
53.68%
Debt ratio change over time
-5.39%
Current Ratio
4.32%
Quick Ratio
3.96%
Cash Position Ratio
2.86%
Performance ratios (change over 4 years) 31-Dec-2018 - 31-Dec-2022
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-30.1%
Return on assets
-68.05%
Return on sales
727.8%
Return on invested capital
160.85%
Total debt ratio
-273.32%
Debt ratio change over time
-2.73%
Current Ratio
-34.78%
Quick Ratio
-33.51%
Cash Position Ratio
-28.34%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CASI | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -14.45% | 1.67% | 33.68% | 7.86% |
| Return on assets | -7.01% | 3.5% | 3.76% | 5.92% |
| Return on sales | -204.97% | 33.1% | 37.17% | 40.11% |
| Return on invested capital | -45.85% | 4.61% | 6.91% | 20.46% |
| Profitability | 0% | 42% | 72% | 81% |
| Total debt ratio | 35.07% | 96.79% | 87.33% | 27.76% |
| Debt ratio change over time | -2.73% | 272.38% | 14.08% | 1.19% |
| Dept financing | 9% | 50% | 24% | 7% |
| Current Ratio | 3.3% | 0.89% | 1.52% | 5.07% |
| Quick Ratio | 2.98% | 0.78% | 1.18% | 4.32% |
| Cash Position Ratio | 1.97% | 0.3% | 0.62% | 2.44% |
| Liquididy | 75% | 9% | 12% | 27% |
| Short-term ratios | CASI | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -18.8% | 18.14% | 79.6% | 5.11% |
| Return on assets | -5.48% | 3.34% | 3.87% | 4.53% |
| Return on sales | -61.7% | 32.51% | 36.49% | 40.56% |
| Return on invested capital | -93.62% | 3.63% | 6.13% | 11.61% |
| Profitability | 0% | 52% | 82% | 77% |
| Total debt ratio | 47.81% | 88.66% | 95.75% | 23.34% |
| Debt ratio change over time | -3.81% | 34.32% | 15.38% | 1.05% |
| Dept financing | 12% | 48% | 36% | 7% |
| Current Ratio | 3.3% | 0.89% | 1.52% | 5.07% |
| Quick Ratio | 2.98% | 0.78% | 1.18% | 4.32% |
| Cash Position Ratio | 1.97% | 0.3% | 0.62% | 2.44% |
| Liquididy | 54% | 12% | 21% | 75% |